EUVIMEDEUVIMED entdecken
Open Access

Does gonadotoxic chemotherapy deplete the ovarian reserve through activation of primordial follicles?

Murat Erden iD, Kutluk H Oktay iD

Human Reproduction · 01.04.2025 · 40 (4) · 571-579

DOI: 10.1093/humrep/deaf024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 22.02.2025. Verfasst von Murat Erden und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA. Hauptthemen laut MEDLINE: Antineoplastic Agents, Ovarian Follicle, Ovarian Reserve. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite significant advances in fertility preservation, no proven pharmacological options exist to protect ovarian primordial follicle reserve from chemotherapy-induced damage. Developing targeted gonadoprotective treatments will require an improved understanding of the molecular mechanisms underlying chemotherapy-induced primordial follicle depletion. While there is robust evidence that gonadotoxic chemotherapy induces primordial follicle death by causing DNA double-strand breaks which trigger apoptotic death, follicle activation leading to ‘burn-out’ of the ovarian reserve has been suggested as an alternative mechanism. Here, we critically evaluated whether primordial follicle activation is a significant mechanism of chemotherapy-induced ovarian reserve depletion in humans. We assessed the causal relationship between chemotherapy exposure and primordial follicle activation by applying the Bradford Hill criteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsOvarian FollicleOvarian ReserveFemaleHumansApoptosisFertility Preservation

Stichwörter der Autor:innen

chemotherapycyclophosphamidefertility preservationovarian damageovarian reserveprimordial follicle

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA.
  • Innovation Institute for Fertility Preservation New York, New York and New Haven, CT, USA.

ORCID-Profile: Murat Erden, Kutluk H Oktay

Förderung

  • NICHD NIH HHS
  • National Institutes of Health

Zitieren

APA

Erden, M., & Oktay, K. H. (2025). Does gonadotoxic chemotherapy deplete the ovarian reserve through activation of primordial follicles?. Human Reproduction, 40(4), 571-579. https://doi.org/10.1093/humrep/deaf024

Vancouver

Erden M, Oktay KH. Does gonadotoxic chemotherapy deplete the ovarian reserve through activation of primordial follicles?. Human Reproduction. 2025;40(4):571-579. doi:10.1093/humrep/deaf024

BibTeX
@article{Erden2025,
  author = {Erden, Murat and Oktay, Kutluk H},
  title = {Does gonadotoxic chemotherapy deplete the ovarian reserve through activation of primordial follicles?},
  journal = {Human Reproduction},
  year = {2025},
  volume = {40},
  number = {4},
  pages = {571--579},
  doi = {10.1093/humrep/deaf024}
}
Kostenlos starten →